tirzepatide pyridoxine dosage chart Microdosing Chart: A Weekly Dose Guide That Works Dr. Friedman's Weight Loss Guide

Clinical data shows an average of 9 to 10% of starting body weight lost by the three-month mark on semaglutide

In this article, well dive into why your thyroid gland plays a crucial role, how GLP-1 medications might interact with thyroid function, and what to know if youre managing both your weight and a thyroid condition

Synthetic incretin receptor agonists are similar to natural incretins and can mimic their effect

Most of whats sold online is industrial-grade, contaminated, or underdosed

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet approved by the MHRA or EMA, with Phase 3 trials ongoing

Zepbound (tirzepatide) is a prescription medication approved by the FDA in November 2023 for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity